241 related articles for article (PubMed ID: 15528069)
41. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
[TBL] [Abstract][Full Text] [Related]
42. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
Wuu CS; Chen J
Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
[TBL] [Abstract][Full Text] [Related]
43. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
Chen Z; Nath R
Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
[TBL] [Abstract][Full Text] [Related]
44. Monte Carlo estimation of dose difference in lung from 192Ir brachytherapy due to tissue inhomogeneity.
Gialousis G; Dimitriadis A; Yakoumakis E
Radiat Prot Dosimetry; 2011 Sep; 147(1-2):287-90. PubMed ID: 21831865
[TBL] [Abstract][Full Text] [Related]
45. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
Abboud F; Scalliet P; Vynckier S
Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
[TBL] [Abstract][Full Text] [Related]
46. Dose parameters of 125I and 192Ir seed sources.
Weaver KA; Smith V; Huang D; Barnett C; Schell MC; Ling C
Med Phys; 1989; 16(4):636-43. PubMed ID: 2770636
[TBL] [Abstract][Full Text] [Related]
47. Monte Carlo-aided dosimetry of the new Bebig IsoSeed 103Pd interstitial brachytherapy seed.
Daskalov GM; Williamson JF
Med Phys; 2001 Oct; 28(10):2154-61. PubMed ID: 11695778
[TBL] [Abstract][Full Text] [Related]
48. Monte Carlo aided dosimetry of the microselectron pulsed and high dose-rate 192Ir sources.
Williamson JF; Li Z
Med Phys; 1995 Jun; 22(6):809-19. PubMed ID: 7565372
[TBL] [Abstract][Full Text] [Related]
49. Thermoluminescent dosimetry of the selectseed 125I interstitial brachytherapy seed.
Anagnostopoulos G; Baltas D; Karaiskos P; Sandilos P; Papagiannis P; Sakelliou L
Med Phys; 2002 May; 29(5):709-16. PubMed ID: 12033566
[TBL] [Abstract][Full Text] [Related]
50. Perturbation of TG-43 parameters of the brachytherapy sources under insufficient scattering materials.
Zehtabian M; Sina S; Faghihi R; Meigooni A
J Appl Clin Med Phys; 2013 May; 14(3):4228. PubMed ID: 23652255
[TBL] [Abstract][Full Text] [Related]
51. Dosimetric properties of the new 125I BrachySeed model LS-1 source.
Chan GH; Prestwich WV
Med Phys; 2002 Feb; 29(2):190-200. PubMed ID: 11865990
[TBL] [Abstract][Full Text] [Related]
52. Measurement of the absorbed dose distribution near an 192Ir intravascular brachytherapy seed using a high-spatial-resolution gel dosimetry system.
Massillon-JL G; Minniti R; Mitch MG; Soares CG
Phys Med Biol; 2012 Jun; 57(11):3407-18. PubMed ID: 22572625
[TBL] [Abstract][Full Text] [Related]
53. Dosimetry parameters of the IRH10 192Ir high dose rate brachytherapy source.
Yi CY; Chun KJ; Hah SH; Kim HM; Lim C
J Radiat Res; 2010; 51(4):485-92. PubMed ID: 20508393
[TBL] [Abstract][Full Text] [Related]
54. Experimental determination of the anisotropy function for the model 200 103Pd "light seed" and derivation of the anisotropy constant based upon the linear quadratic model.
Yue N; Nath R
Med Phys; 2002 Jun; 29(6):1120-9. PubMed ID: 12094982
[TBL] [Abstract][Full Text] [Related]
55. Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements.
Sureka CS; Sunny CS; Subbaiah KV; Aruna P; Ganesan S
Phys Med Biol; 2007 Jan; 52(2):525-37. PubMed ID: 17202631
[TBL] [Abstract][Full Text] [Related]
56. Anisotropy functions for low energy interstitial brachytherapy sources: an EGS4 Monte Carlo study.
Capote R; Mainegra E; López E
Phys Med Biol; 2001 Jan; 46(1):135-50. PubMed ID: 11197668
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive I-125 multi-seed comparison for prostate brachytherapy: dosimetry and visibility analysis.
Al-Qaisieh B; Smith DW; Brearley E; St Clair S; Bownes P
Radiother Oncol; 2007 Aug; 84(2):140-7. PubMed ID: 17588696
[TBL] [Abstract][Full Text] [Related]
58. Dosimetry on transverse axes of 125I and 192Ir interstitial brachytherapy sources.
Nath R; Meigooni AS; Meli JA
Med Phys; 1990; 17(6):1032-40. PubMed ID: 2280732
[TBL] [Abstract][Full Text] [Related]
59. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
60. Monte Carlo dosimetric study of the BEBIG Co-60 HDR source.
Ballester F; Granero D; Pérez-Calatayud J; Casal E; Agramunt S; Cases R
Phys Med Biol; 2005 Nov; 50(21):N309-16. PubMed ID: 16237230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
